Edgewell (EPC) CEO reports vesting, tax withholding and new RSUs

Rhea-AI Filing Summary

Edgewell Personal Care (EPC) reported insider equity transactions by Chief Executive Officer and Director Rod R. Little. On 11/13/2025, 58,612 performance stock equivalents vested and converted into shares of common stock at an exercise price of $0. On the same date, 27,167 shares were withheld to cover tax liabilities at a price of $18.39 per share, leaving Little with 365,818 shares of common stock held directly.

In a related derivative transaction, the original performance award was 166,038 shares, of which only 58,612 vested based on performance criteria, with 107,426 shares cancelled. On 11/14/2025, Little received a grant of 103,420 restricted stock equivalents at an exercise price of $0. One-third of this award will vest and convert into Edgewell common stock on each of 11/14/2026, 11/14/2027, and 11/14/2028, subject to continued employment or certain other events.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LITTLE ROD R

(Last) (First) (Middle)

C/O EDGEWELL PERSONAL CARE COMPANY

6 RESEARCH DRIVE

(Street)

SHELTON CT 06484

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EDGEWELL PERSONAL CARE Co [ EPC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/13/2025		M		58,612	A	$0	392,985	D
Common Stock	11/13/2025		F		27,167(1)	D	$18.39	365,818	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Performance Stock Equivalents 11-11-2022	$0	11/13/2025		M			58,612	11/13/2025	(2)	Common Stock	58,612	$0	0	D
Restricted Stock Equivalents 11/14/2025	$0	11/14/2025		A		103,420		11/14/2026	(3)	Common Stock	103,420	$0	103,420	D

Explanation of Responses:

1. Shares withheld as payment of a tax liability on vesting of performance stock equivalents.

2. Performance Stock Equivalents vested and converted into shares of EPC common stock on 11/13/2025. The original award was 166,038 shares; only 58,612 vested in accordance with the performance criteria. The remaining 107,426 shares were cancelled.

3. One-third of the RSEs will vest and convert into shares of Edgewell common stock on each of 11/14/2026, 11/14/2027 and 11/14/2028 if the Reporting Person is employed on said dates, or all or a portion may vest upon death, disability, change in control or certain termination events.

	/s/ Rod R. Little	11/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did EPC's CEO Rod R. Little report on this Form 4?

Rod R. Little reported that on 11/13/2025, 58,612 performance stock equivalents vested and converted into shares of Edgewell Personal Care (EPC) common stock at an exercise price of $0. He also reported a new grant of 103,420 restricted stock equivalents on 11/14/2025.

How many EPC shares does the CEO own after the reported transactions?

After the reported transactions, Rod R. Little beneficially owns 365,818 shares of EPC common stock directly, as disclosed in Table I of the filing.

How many EPC shares were withheld for taxes in the CEO's Form 4 filing?

The filing states that 27,167 shares of EPC common stock were withheld as payment of a tax liability upon the vesting of performance stock equivalents, at a price of $18.39 per share.

What happened to the CEO's performance stock equivalents in this EPC Form 4?

The original performance stock equivalents award was 166,038 shares. On 11/13/2025, 58,612 vested and converted into EPC common stock, while the remaining 107,426 shares were cancelled because the performance criteria were not met.

What are the terms of the 103,420 restricted stock equivalents granted to EPC's CEO?

The filing reports that 103,420 restricted stock equivalents were granted on 11/14/2025 at an exercise price of $0. One-third of these will vest and convert into Edgewell common stock on each of 11/14/2026, 11/14/2027, and 11/14/2028, if the reporting person remains employed or in certain other events such as death, disability, change in control, or specified termination events.

Did the EPC CEO still hold any performance stock equivalents after these transactions?

No. Following the vesting and conversion of 58,612 performance stock equivalents into EPC common stock on 11/13/2025 and the cancellation of the remaining 107,426, the filing shows 0 performance stock equivalents remaining beneficially owned.